Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Elizabeth David to Carcinoma, Non-Small-Cell Lung

This is a "connection" page, showing publications Elizabeth David has written about Carcinoma, Non-Small-Cell Lung.

 
Connection Strength
  
 
 
6.414
  
  1. Toubat O, Ding L, Ding K, Wightman SC, Atay SM, Harano T, Kim AW, David EA. Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trial. Semin Thorac Cardiovasc Surg. 2024; 36(2):261-270.
    View in: PubMed
    Score: 0.426
  2. Bick KJ, Ding L, Ebner PJ, Kim AW, Atay SM, Wightman SC, McFadden PM, Farias AJ, David EA. Regional Variation in Treatment for Highest-Risk Patients With Non-Small Cell Lung Cancer. Ann Thorac Surg. 2022 04; 113(4):1282-1290.
    View in: PubMed
    Score: 0.385
  3. David EA. Commentary: I Am Happy to Inform You That Thoracotomy Is No Longer Required for Stage IIIA-N2 NSCLC. Semin Thorac Cardiovasc Surg. 2021; 33(2):558.
    View in: PubMed
    Score: 0.372
  4. Toubat O, Atay SM, Kim AW, Ding L, Farias AJ, Ebner PJ, McFadden PM, David EA. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2020 05; 109(5):1512-1520.
    View in: PubMed
    Score: 0.352
  5. Ebner PJ, Ding L, Kim AW, Atay SM, Yao MJ, Toubat O, McFadden PM, Balekian AA, David EA. The Effect of Socioeconomic Status on Treatment and Mortality in Non-Small Cell Lung Cancer Patients. Ann Thorac Surg. 2020 01; 109(1):225-232.
    View in: PubMed
    Score: 0.342
  6. David EA, Atay SM, McFadden PM, Kim AW. Sublobar or Suboptimal: Does Tumor Spread through Air Spaces Signify the End of Sublobar Resections for T1N0 Adenocarcinomas? J Thorac Oncol. 2019 01; 14(1):11-12.
    View in: PubMed
    Score: 0.327
  7. David EA, Andersen SW, Beckett LA, Melnikow J, Clark JM, Brown LM, Cooke DT, Kelly K, Canter RJ. Survival benefits associated with surgery for advanced non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 04; 157(4):1620-1628.
    View in: PubMed
    Score: 0.324
  8. Brown LM, Cooke DT, David EA. Adjuvant Chemotherapy Does Not Improve Survival for Lung Cancer With Chest Wall Invasion. Ann Thorac Surg. 2017 Dec; 104(6):1798-1804.
    View in: PubMed
    Score: 0.302
  9. David EA, Andersen SW, Beckett LA, Melnikow J, Kelly K, Cooke DT, Brown LM, Canter RJ. A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients. Ann Thorac Surg. 2017 Nov; 104(5):1665-1672.
    View in: PubMed
    Score: 0.300
  10. David EA, Clark JM, Cooke DT, Melnikow J, Kelly K, Canter RJ. The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-Small Cell Lung Cancer. J Thorac Oncol. 2017 11; 12(11):1636-1645.
    View in: PubMed
    Score: 0.298
  11. David EA, Daly ME, Li CS, Chiu CL, Cooke DT, Brown LM, Melnikow J, Kelly K, Canter RJ. Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A Propensity-Matched Analysis. J Thorac Oncol. 2017 03; 12(3):437-445.
    View in: PubMed
    Score: 0.286
  12. David EA, Cooke DT, Chen Y, Nijar K, Canter RJ, Cress RD. Does Lymph Node Count Influence Survival in Surgically Resected Non-Small Cell Lung Cancer? Ann Thorac Surg. 2017 Jan; 103(1):226-235.
    View in: PubMed
    Score: 0.276
  13. David EA, Canter RJ, Chen Y, Cooke DT, Cress RD. Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival. Ann Thorac Surg. 2016 Oct; 102(4):1101-9.
    View in: PubMed
    Score: 0.274
  14. David EA, Cooke DT, Chen Y, Perry A, Canter RJ, Cress R. Surgery in high-volume hospitals not commission on cancer accreditation leads to increased cancer-specific survival for early-stage lung cancer. Am J Surg. 2015 Oct; 210(4):643-7.
    View in: PubMed
    Score: 0.256
  15. Cooke DT, Gandara DR, Goodwin NC, Calhoun RF, Lara PN, Mack PC, David EA. Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):36-40.
    View in: PubMed
    Score: 0.235
  16. David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJ. Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size. Ann Thorac Surg. 2013 Jun; 95(6):1872-7; discussion 1877.
    View in: PubMed
    Score: 0.221
  17. Woodard GA, Grau-Sepulveda M, Onaitis MW, Udelsman BV, David EA, Jacobs JP, Kosinski AS, Blasberg JD, Boffa DJ. Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation. Ann Thorac Surg. 2025 May; 119(5):1071-1081.
    View in: PubMed
    Score: 0.124
  18. Antonoff MB, Mitchell KG, Kim SS, Salfity HV, Kotova S, Ripley RT, Neri AL, Sood P, Gandhi SG, Elamin YY, Donington JS, Jones DR, David EA, Swisher SG, Opitz I, Hayanga JWA, Rocco G. The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer. Ann Thorac Surg. 2025 Mar; 119(3):495-508.
    View in: PubMed
    Score: 0.124
  19. Stuart CM, Mott NM, Bronsert MR, Randhawa SK, David EA, Mitchell JD, Meguid RA. The Association Between Sociodemographic Factors and Delays to Minimally Invasive Surgery for Stage IA-IIIA Non-small Cell Lung Cancer. Ann Thorac Surg. 2025 May; 119(5):1082-1091.
    View in: PubMed
    Score: 0.124
  20. Stuart CM, Dyas AR, Bronsert MR, Velopulos CG, Randhawa SK, David EA, Mitchell JD, Meguid RA. The Effect of Social Vulnerability on Initial Stage and Treatment for Non-Small Cell Lung Cancer. Lung Cancer. 2024 02; 188:107452.
    View in: PubMed
    Score: 0.115
  21. Dyas AR, Bronsert MR, Stuart CM, Thomas MB, Schulick RD, Franco SR, Gleisner A, Randhawa SK, David EA, Mitchell JD, Meguid RA. Analyzing the impact of the Coronavirus disease 2019 pandemic on initial oncologic presentation and treatment of non-small cell lung cancer in the United States. J Thorac Cardiovasc Surg. 2024 Aug; 168(2):378-390.e7.
    View in: PubMed
    Score: 0.115
  22. Kidane B, Bott M, Spicer J, Backhus L, Chaft J, Chudgar N, Colson Y, D'Amico TA, David E, Lee J, Najmeh S, Sepesi B, Shu C, Yang J, Swanson S, Stiles B. The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 09; 166(3):637-654.
    View in: PubMed
    Score: 0.111
  23. Axtell AL, David EA, Block MI, Parsons N, Habib R, Muniappan A. Association Between Interstitial Lung Disease and Outcomes After Lung Cancer Resection. Ann Thorac Surg. 2023 09; 116(3):533-541.
    View in: PubMed
    Score: 0.111
  24. Wightman SC, Lee JY, Ding L, Atay SM, Shemanski KA, McFadden PM, David EA, Kim AW. Adjuvant chemotherapy for visceral pleural invasion in 3-4-cm non-small-cell lung cancer improves survival. Eur J Cardiothorac Surg. 2022 06 15; 62(1).
    View in: PubMed
    Score: 0.104
  25. Jang JK, Atay SM, Ding L, David EA, Wightman SC, Kim AW, Ye JC. Patterns of Use of Stereotactic Body Radiation Therapy Compared With Surgery for Definitive Treatment of Primary Early-stage Non-small Cell Lung Cancer. Am J Clin Oncol. 2022 04 01; 45(4):146-154.
    View in: PubMed
    Score: 0.102
  26. Daly ME, Singh N, Ismaila N, Antonoff MB, Arenberg DA, Bradley J, David E, Detterbeck F, Früh M, Gubens MA, Moore AC, Padda SK, Patel JD, Phillips T, Qin A, Robinson C, Simone CB. Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline. J Clin Oncol. 2022 04 20; 40(12):1356-1384.
    View in: PubMed
    Score: 0.100
  27. Atay SM, Amini M, Ding L, David EA, Mcfadden PM, Wightman SC, Kim AW. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection. Ann Thorac Surg. 2021 07; 112(1):197-205.
    View in: PubMed
    Score: 0.093
  28. Xu E, David EA, Ding L, Atay SM, McFadden PM, Wightman SC, Kim AW. Sequence of biologic therapies and surgery affects survival in non-small cell lung cancer. J Surg Oncol. 2020 Aug; 122(2):320-327.
    View in: PubMed
    Score: 0.090
  29. Gandara DR, Mack PC, Bult C, Li T, Lara PN, Riess JW, Astrow SH, Gandour-Edwards R, Cooke DT, Yoneda KY, Moore EH, Pan CX, Burich RA, David EA, Keck JG, Airhart S, Goodwin N, de Vere White RW, Liu ET. Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. Clin Lung Cancer. 2015 May; 16(3):165-72.
    View in: PubMed
    Score: 0.063
  30. Hayes JT, David EA, Qi L, Chen AM, Daly ME. Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung Resection. Clin Lung Cancer. 2015 Sep; 16(5):379-84.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)